Drug intelligence / Profile preview

IL-4Rα siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Inhalation, Intranasal, Intratumoral
01

Overview

IL-4Rα siRNA is a small interfering RNA designed to target and silence the expression of interleukin-4 receptor subunit alpha (IL-4Rα). IL-4Rα is a key component of both Type I and Type II IL-4/IL-13 receptor complexes, which mediate Th2-type immune responses and are implicated in tumor cell survival, metastasis, and resistance to apoptosis. By knocking down IL-4Rα, this siRNA inhibits downstream JAK/STAT6 signaling, leading to reduced cell viability, increased apoptosis, and impaired metastatic growth in various cancer models, such as breast cancer. It is also investigated in preclinical models of respiratory diseases like asthma to reduce airway hyperresponsiveness and inflammation. It is widely used as a research-use-only tool for gene silencing and target validation.

Other names
IL-4R alpha siRNAIL4R alpha siRNAIL 4R alpha siRNAIL-4Rα small interfering RNAIl4ra siRNAIl-4ra siRNAIl 4ra siRNAinterleukin-4 receptor subunit alpha siRNAinterleukin4 receptor subunit alpha siRNAinterleukin 4 receptor subunit alpha siRNA
02

Targets

IL4R (Interleukin-4 receptor alpha subunit)

Beyond the preview

Go deeper on IL-4Rα siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IL-4Rα siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call